HPV, Vaccine-Preventable Diseases
Conditions
Keywords
adolescent, game intervention
Brief summary
This proposed study aims to conduct timely research that promotes vaccine confidence and vaccination of one strongly recommended vaccine with suboptimal uptake rates: Human papillomavirus (HPV) in vulnerable and underserved youth aged 11-14.
Detailed description
The study objectives are: Objective 1: Assess feasibility (participation rate, retention, involvement, satisfaction) of one game-based interventions targeting HPV vaccination. Objective 2: Conduct a pilot RCT with three conditions (Arm 1: HPV game-based intervention; Arm 2: usual care). The investigators will explore patterns of pre- to post-intervention change in theoretical mediators and vaccine intent, and explore levels of vaccine intent and uptake in 90 parent-child dyads of unvaccinated youth aged 11-14.
Interventions
BEHAVIORALvaccination game
A health game to promote HPV vaccination among youth
Sponsors
Michigan State University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
11 Years to 14 Years
Healthy volunteers
Yes
Inclusion criteria
* Child sample: (1) 11-14 years old, (2) speaks and reads English, (3) has never received any doses of the HPV vaccine, (4) is not currently enrolled in another project that involves HPV-related education, and (5) agrees and provides assent to participate in research activities. * Parent sample: (1) parent or legal guardian of the participating child, (2) speak and read English, (3) own a smartphone, (4) agree to receive email and text messages, (5) is not currently enrolled in another project that involves HPV-related education, and (6) agree and provide consent to participate in research activities.
Exclusion criteria
Individuals who do not meet inclusion criteria or refuse to provide consent/assent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of eligible individuals agreeing to participate | T0 (occurs after consenting and before assigning to different study conditions) | Assessed by the % of eligible individuals agreeing to participate |
| Proportion of participants who are retained through follow-up | T2 (occurs two months after completion of the intervention) | Assessed by the % of participants who are retained through follow-up |
| Percentage of participants who complete the intervention and assessments | T2 (occurs two months after completion of the intervention) | Assessed by the % of participants who complete the intervention and assessments |
| Participant satisfaction with the project | T2 (occurs two months after completion of the intervention) | Assessed by two Likert scale questions: (1) are you satisfied with the program? (2) Will you recommend this program to others? Responses: from (1) very dissatisfied/definitely not to (5) very satisfied/definitely yes) |
| Intention to vaccinate the children against HPV | T0 (occurs after consenting and before assigning to different study conditions); T1 (occurs immediately post intervention);T2 (occurs two months after completion of the intervention) | Assessed by a Likert scale question: How likely will you (parent) vaccinate your child against HPV? Responses: (0) no; (1) maybe; (2) yes |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Children receives the first dose of HPV vaccine | T2 (occurs two months after completion of the intervention) | Assessed by one binary question regarding whether or not the child has received the first dose of HPV vaccine. Responses: yes, no |
Countries
United States
Contacts
CONTACTANGELA CHEN, PhD
CONTACTNouran Ghonaim, BS
PRINCIPAL_INVESTIGATORANGELA C CHEN, PhD
Michigan State University
Outcome results
None listed